{"count": 26, "results": [{"_id": "35337177", "pmid": 35337177, "pmcid": "PMC8952430", "title": "Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension", "journal": "Pharmaceuticals (Basel)", "authors": ["Loas G", "Van de Borne P", "Darquennes G", "Le Corre P"], "date": "2022-03-21T00:00:00Z", "doi": "10.3390/ph15030380", "meta_date_publication": "2022 Mar 21", "meta_volume": "15", "meta_issue": "3", "meta_pages": "", "score": 50261.957, "text_hl": "@DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@Chronic kidney disease@@@ and @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@malignant neoplasm@@@ were significant predictors as well as @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ status. ", "citations": {"NLM": "Loas G, Van de Borne P, Darquennes G, Le Corre P. Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension Pharmaceuticals (Basel). 2022 Mar 21;15(3):. PMID: 35337177", "BibTeX": "@article{35337177, title={Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension}, author={Loas G and Van de Borne P and Darquennes G and Le Corre P}, journal={Pharmaceuticals (Basel)}, volume={15}, number={3}}"}}, {"_id": "40702728", "pmid": 40702728, "title": "Amlodipine as an Immunomodulatory Agent in Cancer Therapy: Enhancing Dendritic Cell Activation in Combination with Tumor-associated Antigen.", "journal": "Mol Ther", "authors": ["Wang Z", "Huang X", "Duan L", "Tian S", "Shi C", "Mou Y", "Dong H", "Gao Y", "Weng L"], "date": "2025-07-23T00:00:00Z", "doi": "10.1016/j.ymthe.2025.07.030", "meta_date_publication": "2025 Jul 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.96, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ as an Immunomodulatory Agent in @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@Cancer@@@ Therapy: Enhancing Dendritic Cell Activation in Combination with Tumor-associated Antigen.", "citations": {"NLM": "Wang Z, Huang X, Duan L, Tian S, Shi C, Mou Y, Dong H, Gao Y, Weng L. Amlodipine as an Immunomodulatory Agent in Cancer Therapy: Enhancing Dendritic Cell Activation in Combination with Tumor-associated Antigen. Mol Ther. 2025 Jul 23;():. PMID: 40702728", "BibTeX": "@article{40702728, title={Amlodipine as an Immunomodulatory Agent in Cancer Therapy: Enhancing Dendritic Cell Activation in Combination with Tumor-associated Antigen.}, author={Wang Z and Huang X and Duan L and Tian S and Shi C and Mou Y and Dong H and Gao Y and Weng L}, journal={Mol Ther}}"}}, {"_id": "37909988", "pmid": 37909988, "title": "Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine.", "journal": "Anticancer Res", "authors": ["Shiozaki A", "Kurashima K", "Kudou M", "Shimizu H", "Kosuga T", "Takemoto K", "Arita T", "Konishi H", "Yamamoto Y", "Morimura R", "Komatsu S", "Ikoma H", "Kubota T", "Fujiwara H", "Otsuji E"], "date": "2023-11-01T00:00:00Z", "doi": "10.21873/anticanres.16682", "meta_date_publication": "2023 Nov", "meta_volume": "43", "meta_issue": "11", "meta_pages": "4855-4864", "score": 50251.438, "text_hl": "@<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@Cancer@@@ Stem Cells of @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@ Are Suppressed by the Voltage-gated Calcium Channel Inhibitor @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@.", "citations": {"NLM": "Shiozaki A, Kurashima K, Kudou M, Shimizu H, Kosuga T, Takemoto K, Arita T, Konishi H, Yamamoto Y, Morimura R, Komatsu S, Ikoma H, Kubota T, Fujiwara H, Otsuji E. Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine. Anticancer Res. 2023 Nov;43(11):4855-4864. PMID: 37909988", "BibTeX": "@article{37909988, title={Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine.}, author={Shiozaki A and Kurashima K and Kudou M and Shimizu H and Kosuga T and Takemoto K and Arita T and Konishi H and Yamamoto Y and Morimura R and Komatsu S and Ikoma H and Kubota T and Fujiwara H and Otsuji E}, journal={Anticancer Res}, volume={43}, number={11}, pages={4855-4864}}"}}, {"_id": "33323966", "pmid": 33323966, "title": "Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity.", "journal": "Oncogene", "authors": ["Li C", "Yao H", "Wang H", "Fang JY", "Xu J"], "date": "2021-02-01T00:00:00Z", "doi": "10.1038/s41388-020-01592-6", "meta_date_publication": "2021 Feb", "meta_volume": "40", "meta_issue": "6", "meta_pages": "1128-1146", "score": 50250.96, "text_hl": "Here by drug repurposing screen, we identified @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ as a potent inhibitor of @GENE_CD274 @GENE_29126 @@@PD-L1@@@ expression in @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ cells. ", "citations": {"NLM": "Li C, Yao H, Wang H, Fang JY, Xu J. Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene. 2021 Feb;40(6):1128-1146. PMID: 33323966", "BibTeX": "@article{33323966, title={Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity.}, author={Li C and Yao H and Wang H and Fang JY and Xu J}, journal={Oncogene}, volume={40}, number={6}, pages={1128-1146}}"}}, {"_id": "35020688", "pmid": 35020688, "title": "Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study.", "journal": "J Cardiovasc Pharmacol", "authors": ["Chan TH", "Tsoi MF", "Yung Cheung BM"], "date": "2022-04-01T00:00:00Z", "doi": "10.1097/FJC.0000000000001217", "meta_date_publication": "2022 Apr 1", "meta_volume": "79", "meta_issue": "4", "meta_pages": "577-582", "score": 50250.918, "text_hl": "The @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ incidence rate ratio of @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ relative to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ was 0.94 (0.88-1.01). ", "citations": {"NLM": "Chan TH, Tsoi MF, Yung Cheung BM. Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study. J Cardiovasc Pharmacol. 2022 Apr 1;79(4):577-582. PMID: 35020688", "BibTeX": "@article{35020688, title={Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study.}, author={Chan TH and Tsoi MF and Yung Cheung BM}, journal={J Cardiovasc Pharmacol}, volume={79}, number={4}, pages={577-582}}"}}, {"_id": "35620309", "pmid": 35620309, "title": "Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells.", "journal": "Biomed Rep", "authors": ["Alqudah MAY", "Al-Samman R", "Azaizeh M", "Alzoubi KH"], "date": "2022-06-01T00:00:00Z", "doi": "10.3892/br.2022.1533", "meta_date_publication": "2022 Jun", "meta_volume": "16", "meta_issue": "6", "meta_pages": "50", "score": 50249.215, "text_hl": "Fortunately, the function of @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ channels can be manipulated pharmacologically using calcium channel blockers (CCBs). @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, a @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ CCB, has been demonstrated to exert cytotoxic effects in several types of @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancers@@@. ", "citations": {"NLM": "Alqudah MAY, Al-Samman R, Azaizeh M, Alzoubi KH. Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells. Biomed Rep. 2022 Jun;16(6):50. PMID: 35620309", "BibTeX": "@article{35620309, title={Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells.}, author={Alqudah MAY and Al-Samman R and Azaizeh M and Alzoubi KH}, journal={Biomed Rep}, volume={16}, number={6}, pages={50}}"}}, {"_id": "38045916", "pmid": 38045916, "pmcid": "PMC10691487", "title": "The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT-Medicare linked data", "journal": "Front Cardiovasc Med", "authors": ["Du XL", "Martinez J", "Yamal JM", "Simpson LM", "Davis BR"], "date": "2023-11-17T00:00:00Z", "doi": "10.3389/fcvm.2023.1272385", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1272385", "score": 50244.465, "text_hl": "The 18-year cumulative incidence rate of @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ other than @DISEASE_Skin_Neoplasms @DISEASE_MESH:D012878 @@@non-melanoma skin cancer@@@ from Medicare inpatient claims was 23.9% for @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, 23.4% for @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and 25.3% for @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Du XL, Martinez J, Yamal JM, Simpson LM, Davis BR. The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT-Medicare linked data Front Cardiovasc Med. 2023;10():1272385. PMID: 38045916", "BibTeX": "@article{38045916, title={The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT-Medicare linked data}, author={Du XL and Martinez J and Yamal JM and Simpson LM and Davis BR}, journal={Front Cardiovasc Med}, volume={10}, pages={1272385}}"}}, {"_id": "33566246", "pmid": 33566246, "title": "Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells.", "journal": "Ann Surg Oncol", "authors": ["Shiozaki A", "Katsurahara K", "Kudou M", "Shimizu H", "Kosuga T", "Ito H", "Arita T", "Konishi H", "Komatsu S", "Kubota T", "Fujiwara H", "Okamoto K", "Otsuji E"], "date": "2021-09-01T00:00:00Z", "doi": "10.1245/s10434-021-09645-0", "meta_date_publication": "2021 Sep", "meta_volume": "28", "meta_issue": "9", "meta_pages": "5400-5411", "score": 50243.684, "text_hl": "@<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@Tumor@@@ volumes were significantly smaller in a xenograft nude @SPECIES_10090 @@@mouse@@@ model treated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ or @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@ in combination with @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@ than in that treated with @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@ alone. ", "citations": {"NLM": "Shiozaki A, Katsurahara K, Kudou M, Shimizu H, Kosuga T, Ito H, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells. Ann Surg Oncol. 2021 Sep;28(9):5400-5411. PMID: 33566246", "BibTeX": "@article{33566246, title={Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells.}, author={Shiozaki A and Katsurahara K and Kudou M and Shimizu H and Kosuga T and Ito H and Arita T and Konishi H and Komatsu S and Kubota T and Fujiwara H and Okamoto K and Otsuji E}, journal={Ann Surg Oncol}, volume={28}, number={9}, pages={5400-5411}}"}}, {"_id": "40701313", "pmid": 40701313, "title": "Amlodipine synergizes with temozolomide against glioma stem cells by modulating MGMT expression through downregulation of the AKT/GSK3beta/beta-catenin axis.", "journal": "Cell Signal", "authors": ["Zhang X", "Li Z", "Wen P", "Yin N", "Zhang Z", "Zhong T", "Xia F", "Pan J", "Liu L", "Dong J"], "date": "2025-07-21T00:00:00Z", "doi": "10.1016/j.cellsig.2025.112012", "meta_date_publication": "2025 Jul 21", "meta_volume": "135", "meta_issue": "", "meta_pages": "112012", "score": 50243.113, "text_hl": "Furthermore, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ significantly reduced @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@ volume and prolonged median survival of @<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@tumor@@@-bearing @SPECIES_10090 @@@mice@@@ in vivo. ", "citations": {"NLM": "Zhang X, Li Z, Wen P, Yin N, Zhang Z, Zhong T, Xia F, Pan J, Liu L, Dong J. Amlodipine synergizes with temozolomide against glioma stem cells by modulating MGMT expression through downregulation of the AKT/GSK3beta/beta-catenin axis. Cell Signal. 2025 Jul 21;135():112012. PMID: 40701313", "BibTeX": "@article{40701313, title={Amlodipine synergizes with temozolomide against glioma stem cells by modulating MGMT expression through downregulation of the AKT/GSK3beta/beta-catenin axis.}, author={Zhang X and Li Z and Wen P and Yin N and Zhang Z and Zhong T and Xia F and Pan J and Liu L and Dong J}, journal={Cell Signal}, volume={135}, pages={112012}}"}}, {"_id": "40089189", "pmid": 40089189, "title": "Involvement of GSK-3beta, NF-kappaB, PPARgamma, and apoptosis in amlodipine's anticancer effect in BALB/c mice.", "journal": "Toxicol Appl Pharmacol", "authors": ["Arafa EA", "Abdel-Fattah MM", "Hassanein EHM", "Buabeid MA", "Mohamed WR"], "date": "2025-03-13T00:00:00Z", "doi": "10.1016/j.taap.2025.117298", "meta_date_publication": "2025 Mar 13", "meta_volume": "498", "meta_issue": "", "meta_pages": "117298", "score": 50243.066, "text_hl": "The present work aims to assess the potential anti-@<m>DISEASE_Neoplasms</m> @DISEASE_MESH:D009369 @@@cancer@@@ effectiveness of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, a calcium channel blocker, on @SPECIES_10090 @@@murine@@@ @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@ via modulating @GENE_GSK3B @GENE_56637 @@@GSK-3beta@@@, @GENE_NFKB1 @GENE_18033 @@@NF-kappaB@@@, @GENE_PPARG @GENE_19016 @@@PPARgamma@@@, and apoptosis. ", "citations": {"NLM": "Arafa EA, Abdel-Fattah MM, Hassanein EHM, Buabeid MA, Mohamed WR. Involvement of GSK-3beta, NF-kappaB, PPARgamma, and apoptosis in amlodipine's anticancer effect in BALB/c mice. Toxicol Appl Pharmacol. 2025 Mar 13;498():117298. PMID: 40089189", "BibTeX": "@article{40089189, title={Involvement of GSK-3beta, NF-kappaB, PPARgamma, and apoptosis in amlodipine's anticancer effect in BALB/c mice.}, author={Arafa EA and Abdel-Fattah MM and Hassanein EHM and Buabeid MA and Mohamed WR}, journal={Toxicol Appl Pharmacol}, volume={498}, pages={117298}}"}}]}